APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Venlafaxine Hydrochloride Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Venlafaxine Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174045710327 December 2025184 pages

Choose your research edition.

Industry ResearchVenlafaxine Hydrochloride Capsules Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Venlafaxine Hydrochloride Capsules Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Venlafaxine Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Venlafaxine Hydrochloride Capsules Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Venlafaxine Hydrochloride Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Venlafaxine Hydrochloride Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Venlafaxine Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Venlafaxine Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venlafaxine Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Venlafaxine Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Venlafaxine Hydrochloride Capsules include Suzhou Fourth Pharmaceutical Factory Co., Ltd., Sichuan Hezheng Pharmaceutical Co., Ltd., Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd., Shanghai Xinya Pharmaceutical Minhang Co., Ltd., Shandong Xinqi Pharmaceutical Co., Ltd., Lepu Pharmaceutical Co., Ltd., Chengdu Kanghong Pharmaceutical Group Co., Ltd., Chengdu Hengrui Pharmaceutical Co., Ltd. and Chengdu Beite Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Venlafaxine Hydrochloride Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Venlafaxine Hydrochloride Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Venlafaxine Hydrochloride Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Venlafaxine Hydrochloride Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Venlafaxine Hydrochloride Capsules Segment by Company

Suzhou Fourth Pharmaceutical Factory Co., Ltd.

Sichuan Hezheng Pharmaceutical Co., Ltd.

Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd.

Shanghai Xinya Pharmaceutical Minhang Co., Ltd.

Shandong Xinqi Pharmaceutical Co., Ltd.

Lepu Pharmaceutical Co., Ltd.

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Chengdu Hengrui Pharmaceutical Co., Ltd.

Chengdu Beite Pharmaceutical Co., Ltd.

Venlafaxine Hydrochloride Capsules Segment by Type

Each Tablet Contains 75 mg of Venlafaxine Hydrochloride

Each Tablet Contains 150 mg of Venlafaxine Hydrochloride

Venlafaxine Hydrochloride Capsules Segment by Application

Hospital

Clinic

Other

Venlafaxine Hydrochloride Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venlafaxine Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venlafaxine Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venlafaxine Hydrochloride Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Venlafaxine Hydrochloride Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Venlafaxine Hydrochloride Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Venlafaxine Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Venlafaxine Hydrochloride Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Venlafaxine Hydrochloride Capsules Industry Trends Table 2. Venlafaxine Hydrochloride Capsules Industry Drivers Table 3. Venlafaxine Hydrochloride Capsules Industry Opportunities and Challenges Table 4. Venlafaxine Hydrochloride Capsules Industry Restraints Table 5. Global Venlafaxine Hydrochloride Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Venlafaxine Hydrochloride Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Manufacturers Table 9. Global Venlafaxine Hydrochloride Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Venlafaxine Hydrochloride Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Venlafaxine Hydrochloride Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Venlafaxine Hydrochloride Capsules Manufacturers, Product Type & Application Table 13. Global Venlafaxine Hydrochloride Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Venlafaxine Hydrochloride Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Each Tablet Contains 75 mg of Venlafaxine Hydrochloride Table 17. Major Manufacturers of Each Tablet Contains 150 mg of Venlafaxine Hydrochloride Table 18. Global Venlafaxine Hydrochloride Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Venlafaxine Hydrochloride Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Venlafaxine Hydrochloride Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Type (2021-2026) Table 22. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Type (2027-2032) Table 23. Global Venlafaxine Hydrochloride Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Venlafaxine Hydrochloride Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Venlafaxine Hydrochloride Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Venlafaxine Hydrochloride Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Venlafaxine Hydrochloride Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Venlafaxine Hydrochloride Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Application (2021-2026) Table 35. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Application (2027-2032) Table 36. Global Venlafaxine Hydrochloride Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Venlafaxine Hydrochloride Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Venlafaxine Hydrochloride Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Venlafaxine Hydrochloride Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Venlafaxine Hydrochloride Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Region (2021-2026) Table 44. Global Venlafaxine Hydrochloride Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Venlafaxine Hydrochloride Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Venlafaxine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Venlafaxine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Venlafaxine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Venlafaxine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Venlafaxine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Venlafaxine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Venlafaxine Hydrochloride Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Venlafaxine Hydrochloride Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Venlafaxine Hydrochloride Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Region (2027-2032) Table 63. Suzhou Fourth Pharmaceutical Factory Co., Ltd. Company Information Table 64. Suzhou Fourth Pharmaceutical Factory Co., Ltd. Business Overview Table 65. Suzhou Fourth Pharmaceutical Factory Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Suzhou Fourth Pharmaceutical Factory Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 67. Suzhou Fourth Pharmaceutical Factory Co., Ltd. Recent Development Table 68. Sichuan Hezheng Pharmaceutical Co., Ltd. Company Information Table 69. Sichuan Hezheng Pharmaceutical Co., Ltd. Business Overview Table 70. Sichuan Hezheng Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sichuan Hezheng Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 72. Sichuan Hezheng Pharmaceutical Co., Ltd. Recent Development Table 73. Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Company Information Table 74. Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Business Overview Table 75. Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 77. Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Recent Development Table 78. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information Table 79. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview Table 80. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 82. Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Development Table 83. Shandong Xinqi Pharmaceutical Co., Ltd. Company Information Table 84. Shandong Xinqi Pharmaceutical Co., Ltd. Business Overview Table 85. Shandong Xinqi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shandong Xinqi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 87. Shandong Xinqi Pharmaceutical Co., Ltd. Recent Development Table 88. Lepu Pharmaceutical Co., Ltd. Company Information Table 89. Lepu Pharmaceutical Co., Ltd. Business Overview Table 90. Lepu Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lepu Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 92. Lepu Pharmaceutical Co., Ltd. Recent Development Table 93. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information Table 94. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview Table 95. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 97. Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Development Table 98. Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information Table 99. Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview Table 100. Chengdu Hengrui Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chengdu Hengrui Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 102. Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Development Table 103. Chengdu Beite Pharmaceutical Co., Ltd. Company Information Table 104. Chengdu Beite Pharmaceutical Co., Ltd. Business Overview Table 105. Chengdu Beite Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Chengdu Beite Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio Table 107. Chengdu Beite Pharmaceutical Co., Ltd. Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Venlafaxine Hydrochloride Capsules Distributors List Table 111. Venlafaxine Hydrochloride Capsules Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Venlafaxine Hydrochloride Capsules Product Image Figure 2. Global Venlafaxine Hydrochloride Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Venlafaxine Hydrochloride Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Venlafaxine Hydrochloride Capsules Sales (2021-2032) & (K Units) Figure 5. Global Venlafaxine Hydrochloride Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Venlafaxine Hydrochloride Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Each Tablet Contains 75 mg of Venlafaxine Hydrochloride Image Figure 9. Each Tablet Contains 150 mg of Venlafaxine Hydrochloride Image Figure 10. Global Venlafaxine Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Venlafaxine Hydrochloride Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Venlafaxine Hydrochloride Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Venlafaxine Hydrochloride Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Venlafaxine Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Venlafaxine Hydrochloride Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Venlafaxine Hydrochloride Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Venlafaxine Hydrochloride Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Venlafaxine Hydrochloride Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Venlafaxine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Venlafaxine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Venlafaxine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 39. China Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Venlafaxine Hydrochloride Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Venlafaxine Hydrochloride Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Venlafaxine Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Venlafaxine Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Venlafaxine Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Venlafaxine Hydrochloride Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Venlafaxine Hydrochloride Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Each Tablet Contains 75 mg of Venlafaxine Hydrochloride
  • Each Tablet Contains 150 mg of Venlafaxine Hydrochloride
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Suzhou Fourth Pharmaceutical Factory Co., Ltd.
  • Sichuan Hezheng Pharmaceutical Co., Ltd.
  • Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd.
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  • Shandong Xinqi Pharmaceutical Co., Ltd.
  • Lepu Pharmaceutical Co., Ltd.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Chengdu Hengrui Pharmaceutical Co., Ltd.
  • Chengdu Beite Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Venlafaxine Hydrochloride Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Venlafaxine Hydrochloride Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Venlafaxine Hydrochloride Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Venlafaxine Hydrochloride Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Venlafaxine Hydrochloride Capsules Market Dynamics
  1. 2.1 Venlafaxine Hydrochloride Capsules Industry Trends
  2. 2.2 Venlafaxine Hydrochloride Capsules Industry Drivers
  3. 2.3 Venlafaxine Hydrochloride Capsules Industry Opportunities and Challenges
  4. 2.4 Venlafaxine Hydrochloride Capsules Industry Restraints
3 Venlafaxine Hydrochloride Capsules Market by Manufacturers
  1. 3.1 Global Venlafaxine Hydrochloride Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Venlafaxine Hydrochloride Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Venlafaxine Hydrochloride Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Venlafaxine Hydrochloride Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Venlafaxine Hydrochloride Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Venlafaxine Hydrochloride Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Venlafaxine Hydrochloride Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Venlafaxine Hydrochloride Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Venlafaxine Hydrochloride Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Venlafaxine Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Venlafaxine Hydrochloride Capsules Market by Type
  1. 4.1 Venlafaxine Hydrochloride Capsules Type Introduction
  2. 4.1.1 Each Tablet Contains 75 mg of Venlafaxine Hydrochloride
  3. 4.1.2 Each Tablet Contains 150 mg of Venlafaxine Hydrochloride
  4. 4.2 Global Venlafaxine Hydrochloride Capsules Sales by Type
  5. 4.2.1 Global Venlafaxine Hydrochloride Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Venlafaxine Hydrochloride Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Venlafaxine Hydrochloride Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Venlafaxine Hydrochloride Capsules Revenue by Type
  9. 4.3.1 Global Venlafaxine Hydrochloride Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Venlafaxine Hydrochloride Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Type (2021-2032)
5 Venlafaxine Hydrochloride Capsules Market by Application
  1. 5.1 Venlafaxine Hydrochloride Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Venlafaxine Hydrochloride Capsules Sales by Application
  6. 5.2.1 Global Venlafaxine Hydrochloride Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Venlafaxine Hydrochloride Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Venlafaxine Hydrochloride Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Venlafaxine Hydrochloride Capsules Revenue by Application
  10. 5.3.1 Global Venlafaxine Hydrochloride Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Venlafaxine Hydrochloride Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Application (2021-2032)
6 Global Venlafaxine Hydrochloride Capsules Sales by Region
  1. 6.1 Global Venlafaxine Hydrochloride Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Venlafaxine Hydrochloride Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Venlafaxine Hydrochloride Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Venlafaxine Hydrochloride Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Venlafaxine Hydrochloride Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Venlafaxine Hydrochloride Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Venlafaxine Hydrochloride Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Venlafaxine Hydrochloride Capsules Revenue by Region
  1. 7.1 Global Venlafaxine Hydrochloride Capsules Revenue by Region
  2. 7.1.1 Global Venlafaxine Hydrochloride Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Venlafaxine Hydrochloride Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Venlafaxine Hydrochloride Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Venlafaxine Hydrochloride Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Venlafaxine Hydrochloride Capsules Revenue (2021-2032)
  8. 7.2.2 North America Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Venlafaxine Hydrochloride Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Venlafaxine Hydrochloride Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Venlafaxine Hydrochloride Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Suzhou Fourth Pharmaceutical Factory Co., Ltd.
  2. 8.1.1 Suzhou Fourth Pharmaceutical Factory Co., Ltd. Company Information
  3. 8.1.2 Suzhou Fourth Pharmaceutical Factory Co., Ltd. Business Overview
  4. 8.1.3 Suzhou Fourth Pharmaceutical Factory Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Suzhou Fourth Pharmaceutical Factory Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  6. 8.1.5 Suzhou Fourth Pharmaceutical Factory Co., Ltd. Recent Developments
  7. 8.2 Sichuan Hezheng Pharmaceutical Co., Ltd.
  8. 8.2.1 Sichuan Hezheng Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Sichuan Hezheng Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Sichuan Hezheng Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Hezheng Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  12. 8.2.5 Sichuan Hezheng Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  18. 8.3.5 Sichuan Sichuan University Huaxi Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd.
  20. 8.4.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Company Information
  21. 8.4.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Business Overview
  22. 8.4.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  24. 8.4.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd. Recent Developments
  25. 8.5 Shandong Xinqi Pharmaceutical Co., Ltd.
  26. 8.5.1 Shandong Xinqi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shandong Xinqi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shandong Xinqi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shandong Xinqi Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  30. 8.5.5 Shandong Xinqi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Lepu Pharmaceutical Co., Ltd.
  32. 8.6.1 Lepu Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Lepu Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Lepu Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lepu Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  36. 8.6.5 Lepu Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  38. 8.7.1 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Company Information
  39. 8.7.2 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Business Overview
  40. 8.7.3 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  42. 8.7.5 Chengdu Kanghong Pharmaceutical Group Co., Ltd. Recent Developments
  43. 8.8 Chengdu Hengrui Pharmaceutical Co., Ltd.
  44. 8.8.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  48. 8.8.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Chengdu Beite Pharmaceutical Co., Ltd.
  50. 8.9.1 Chengdu Beite Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Chengdu Beite Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Chengdu Beite Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Beite Pharmaceutical Co., Ltd. Venlafaxine Hydrochloride Capsules Product Portfolio
  54. 8.9.5 Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Venlafaxine Hydrochloride Capsules Value Chain Analysis
  2. 9.1.1 Venlafaxine Hydrochloride Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Venlafaxine Hydrochloride Capsules Production Mode & Process
  6. 9.2 Venlafaxine Hydrochloride Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Venlafaxine Hydrochloride Capsules Distributors
  9. 9.2.3 Venlafaxine Hydrochloride Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst